2024 ACA Nashville Program Book_154th Congress of Correction

staff have faced civil lawsuits seeking monetary awards and other relief for failure to provide withdrawal management services. Treatment for OUD in carceral settings is also imperative as substance-related overdose is the third leading cause of death in jails, following illness and suicide. The revised 42 CFR Part 8 rules clearly and unequivocally state that if a carceral setting has registered as a hospital/clinic, it can treat patients with methadone under the exemption available to hospitals/clinics. Under this exemption, the hospital/clinic can dispense methadone for opioid withdrawal syndrome (OWS) and/or treatment of OUD to patients, provided they have an additional diagnosis besides OWS and/or OUD. The guidance does not list or otherwise specify the additional diagnoses that are required to use this option, which gives some leeway to the clinician. There should be clear documentation in the medical record identifying what additional diagnoses the patient has. This session will cover the effectiveness for medications for opioid use disorder (MOUD), what the use of the hospital/clinic designation

in carceral settings means, and how to operationalize use of methadone effectively for the treatment of OWS and OUD in carceral settings. Learning Objectives: • Participants will be able to understand the effectiveness of medications for opioid use disorder (MOUD). • Participants will be able to understand the hospital/clinic designation and how it can expand access to methadone in carceral settings. • Participants will be able to understand exemplary practices in carceral settings for the treatment of opioid use disorder with methadone. Moderator: Gary Junker , Ph.D., HSP-P, Deputy Secretary, Division of Comprehensive Health Services, North Carolina Department of Adult Correction, Raleigh, North Carolina Speaker: Kelly S. Ramsey , M.D., MPH, M.A., FACP, DFASAM, Addiction Medicine Physician and Harm Reduction Consultant, Kelly S Ramsey Consulting, Olivebridge, New York; Catherine Smith , M.D., Addiction Medical Director, Washington State Department of Corrections, Turnwater, Washington

Thursday, Aug. 15 ▼ 10–11:30 a.m.

WORKSHOPS

84 — ACA 154 th Congress of Correction | Nashville